Paul Hastings and Latham & Watkins were legal advisors on a recent listing application sponsored by J.P. Morgan Chase & Co. that was returned by the Hong Kong Stock Exchange for due diligence issues.
On March 29, the stock exchange sent back the listing filing of Chinese pharmaceutical company Shenhua Health Holdings Ltd., whose sole sponsor was J.P. Morgan Securities (Far East) Ltd. According to the Wall Street Journal, the U.S. bank is the first global investment bank in Hong Kong to have its sponsored application returned by the exchange.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
